Juggernaut Partners III GP, L.P. is Director & 10% Owner at Petros Pharmaceuticals, Inc. (PTPI). They have made 1 open-market trade across 1 company since 2021, most recently 2021-12-22.
CIK 0001835421
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTPI | 5,703,544 | $360K |
Shares reported on the most recent Form 4, priced at the 2022-01-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTPI | BUY | 2021-12-22 | 2022-01-03 | $3.43 | $1.0M | -15.7% | -48.4% | -59.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.